Dual antiplatelet therapy (DAPT), i.e., aspirin plus P2Y12 inhibitors, is used for secondary prevention of coronary events and protection against stent thrombosis but does not provide complete protection against stroke in AF [3-5]. The gene discussed is P2RY12; the disease is Stroke.